Research News

New Markey Initiative Helps Affiliates Deliver Cancer Care Closer to Home

Aug 17, 2021, 7:20 AM

The initiative aims to create a connected, integrated statewide cancer provider network. 40% of all new cancer cases in Kentucky are directly or indirectly cared for by Markey.

Preventing Cancer Recurrence with Coffee? Markey Launches Unique Clinical Trial

Apr 26, 2021, 8:43 AM

The UK Markey Cancer Center has officially launched a unique new clinical trial to test whether Artemisia annua extract can prevent ovarian cancer recurrence.

Markey’s ACTION Program Develops Cancer Education Curriculum for Appalachian Schools

Feb 19, 2021, 9:30 AM

The curriculum includes information on cancer data and risk factors in the region, follows national and state science and health education standards, and is tailored to cultural aspects of Appalachian Kentucky.

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

Feb 1, 2021, 1:18 PM

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

Jan 12, 2021, 8:18 AM

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Williams Named Assistant Director for Cancer Health Equity at Markey

Nov 10, 2020, 8:22 AM

A major initiative of Williams and the Markey Community Impact Office will be the organization and expansion of Markey’s research and outreach portfolio that is focused on reducing cancer and other health disparities based on race/ethnicity, socioeconomic status, etc.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Oct 29, 2020, 8:29 AM

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Evers_Mark_Director%20Markey%20Cancer%20Ctr_1.jpg

Evers Elected to the National Academy of Medicine

Oct 20, 2020, 8:18 AM

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

UK Study Highlights Need for Genetic Testing for Kentucky Patients with Lung Cancer

Sep 23, 2020, 9:58 AM

Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib.

Nathan%20Vanderford%20headshot%20on%20canvas.jpg

Vanderford Honored With Hartford-Nicholson Award From SRAI

Sep 3, 2020, 8:47 AM

In 2018, Vanderford was also named a recipient of the SRAI Mid-Career Level Excellence Award. Vanderford also serves as assistant director for research at the UK Markey Cancer Center, where he oversees a special oncology training program for Appalachian students, ACTION.

Filter News

Unit

News type

Topic

Series